• Date

  • Content Type

  • Reset


Webinar: Experts Discuss Avenues to Improve Biosimilar Development Efficiency


By Skylar Jeremias, Senior Editor, The Center for Biosimilars

A webinar hosted by Biopharma Excellence featured an in-depth discussion on the ways that updated guidelines, a reduction in...


The Right Materials for Success in Bioprinting


By Elena Meurer & Mariya Gromova

Bioprinting has enormous life-changing potential, but it is a complicated field with many regulatory hurdles.


Navigating the global supply of starting materials for cell-based therapies


By Dr Elena Meurer, Dr Jennifer Sales

The use of biological starting materials in the development of allogeneic cell-based therapies poses several challenges


The great debate


By Dr Christian K Schneider

There are a variety of obstacles to the commercialisation of advanced therapies. Dr Christian K

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more